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prompt motivation for larger and well controlled cohort
studies.
http://dx.doi:10.1016/j.jsha.2016.04.010
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As the number of cardiac device implantations are on
a rise, there is a parallel increase in their long-term com-
plications including device-related infection that will
require lead extraction. As the detachment of fibrosed
debris reaching the pulmonary trunk can occur during
the extraction, the risk of developing new-onset Pulmon-
ary Hypertension (P. HTN) increases with every extrac-
tion. Yet, there is paucity of evidence to support such
claim. Given the clinical significance of such findings,
we sought to determine the risk. A chart review of 113
patients whom underwent lead extraction at Prince Sul-
tan Cardiac Center in Saudi Arabia during the period
of Jan, 2002 to Jul, 2015 was carried out. Six patients
had lead extraction twice, making the total number of
extractions to be 119. Of this study cohort, only 45 cases
had Pulmonary Artery Systolic Pressure (PASP) mea-
surement via Transthoracic Echocardiography (TTE)
prior to and after device extraction. PASP measurements
were obtained as reported whether a single measure-
ment or a range between two readings, and an average
was calculated in case of two readings. A difference of
10 mmHg or more in the PASP, whether progression or
improvement, was considered clinically significant.Med-
ian follow up of TTE after lead and device extraction
was 5 months. Out of 45 patients, 31 (68.9%) were males
and 14 (31.1%) were females. Average age was 46.5
(SD = 17) years. Eleven patients (24.4%) experienced a
significant increase of PASP after lead extraction (10
had normal pressure readings before extraction, and only
one had progression to a more severe form of the dis-
ease), 9 patients (20.0%) showed improvement, and the
remaining (55.6%) did not show any significant change
in PASP. Average implantation-to-extraction duration of
the leads was higher among those who had no pressure
difference (50.6 vs. 23.3 months). When looking through
potential predictors that may increase the likelihood of
developing P. HTN, there was no association with a
pre-existing lead-attached vegetation (2 patients only),
nor the type of lead (6 high-voltage vs. 5 pacing leads
across the tricuspid valve). In patients who developed
P. HTN, 8 (72.7%) had their devices extracted as a result
of a complicated infection (wound infections and/or
infective endocarditis), as opposed to 3 (27.3%) whom
underwent device extraction for other indications. Our
simple descriptive study showed that the risk of develop-
ing P. HTN following lead and device extraction is negli-
gible. However, our findings should be interpreted in the
light of the limitations such as a small sample size and
lack of comparable control group. Paucity of data and evi-
dence on the long-term complications subsequent to
device and lead extractions will be a subject of further
exploration given the potential connection to patient out-
comes and management.
http://dx.doi:10.1016/j.jsha.2016.04.011
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Syncope is defined as a transient loss of consciousness
and absence of postural tone followed by spontaneous
recovery. Neurally mediated syncope (vasovagal) and
idiopathic unexplained syncope (US) are the most com-
mon causes of syncope. Syncope is a very limiting disease
that, if recurrent, affects the patients’ physical and psycho-
logical health. Our objective from this study is to measure
the prevalence of psychiatric symptoms among patients
with US. All patients (>12 years) with vasovagal or US
who were evaluated in King Khalid University Hospital
were identified. Echocardiography and table tilt test
reports were reviewed and patients who had cardiac syn-
cope (due to arrhythmia or structural heart disease) were
excluded (N = 18). Ninety-four patients were included for
further psychiatric assessment. The patients were con-
tacted to fill the Symptoms Checklist-90-Revised (SCL-
90-R), which is a self-reporting questionnaire used to eval-
uate traits of depression, anxiety, somatization disorder
and phobia. SCL-90-R scale has been translated to Arabic
and validated in previous studies. Of the included cohort,
43 responded to fill the assessment scale, and 51 were
excluded due to failure of communication (N = 41) or refu-
sal to participate (N = 10). A control group was recruited
with a case: control ratio of 1:3 matching for age, gender,
and chronic illnesses.There were 43 patients and 129 con-
trol subjects, with predominance of females (67.4%) and an
average age of 33.8 (SD = 16). There was no difference in
average scores of depression (13 vs. 14.53, P = 0.31), anxiety
(11.3 vs. 10.4, P = 0.51), or phobia (5.4 vs. 5.2, P = 0.88). How-
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ever, the syncope group had a higher average score for
somatization disorder (18.53 vs. 13.66, P = 0.002). Binary
logistic regression model was measured after grouping
the cohort into above and below median scores. After
adjusting for age, gender, and chronic illnesses, the asso-
ciation between syncope and somatization disorder
remained significant (OR = 3.75, CI; 1.72, 8.15, P = 0.001).
Despite no statistical significance, when looking at the
effect size, having an anxiety score above the median
was 52% higher in cases compared to controls (OR = 1.52,
CI; 0.74, 3.14, P = 0.255). A sub-analysis of the case group
was applied and showed that patients who had multiple
syncopal attacks (6 or more) had higher average scores of
depression, anxiety, phobia and somatization disorder
compared to those who had less than 6 attacks (Table).
Patients with vasovagal or US have similar incidence of
depression, anxiety or phobia symptoms and higher inci-
dence of somatization symptoms compared to control sub-
jects. However, recurrent and more frequent attacks of
syncope was predictive of more deteriorative psychologi-
cal profile for all four domains. Our findings should
prompt motivation to study the effectiveness of psycholo-
gical intervention in patients with recurrent syncope.
http://dx.doi:10.1016/j.jsha.2016.04.012
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Information is limited regarding the knowledge and
attitudes of physicians in Saudi Arabia involved in the
referral of patients for implantable cardioverter-
defibrillator (ICD) and cardiac resynchronization and
defibrillation therapy (CRT-D) devices implantation. As
such knowledge is the key to provide the patient with
an important treatment, we aimed for its assessment.
We conducted personal interviews with physicians
involved in treating patients with heart failure. We
included all hospitals in Riyadh region that has no car-
diac electrophysiology service. Every participant was
met in person and received an oral questionnaire that
aims to assess basic knowledge about ICD and CRT.63
physicians were met from 13 hospitals (14 consultants
and 49 specialist). 41% of participants use 635% as the
LVEF criterion for ICD referral in patients with cardio-
myopathy. 30% of participants use 635% as the LVEF cri-
terion for CRT referral. 24% of participants were not
aware about CRT as a therapy for patients with heart fail-
ure. 50% of the consultants use 635% for ICD and CRT
referral. 70% of the participants think that ICD may
improve heart failure symptoms. 45% of participants
who were about CRT do not think that CRT-D may pre-
vent sudden death due to arrhythmia.There is a lack of
knowledge with current clinical guidelines regarding
ICD and CRT implantation. This finding highlights the
need to improve the dissemination of guidelines to prac-
titioners involved in managing patients with heart failure
in an effort to improve ICD and CRT utilization.
http://dx.doi:10.1016/j.jsha.2016.04.013
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Device therapy for conduction abnormalities, heart
failure, primary or secondary SCD preventions is under
delivered to requiring patients. Most of these devices
are implanted at tertiary care centers in major cities of
most countries. This makes the availability of these
guideline guided therapies to a very small percentage
of needy patients. Implant of such devices at a secondary
hospital (without a cardiac cath lab) with training of pre-
viously novice hospital staff and available resources as
well as support of the industry is an alternative and very
viable option to have such important therapy delivered to
requiring patients. The usage of simple-readily available-
C-arm in operating theatre (OR) or the interventional
radiology suite can be utilized for this purpose. OR nur-
sing staff and radiology technicians can be trained –with
help of nursing education department– to help in such
procedures over a relatively short period. Technical sup-
port utilized from the vendors representatives is an alter-
native to face the lack of EP technicians in local or
international market. The follow up of these patients in
OPD can be organized with help of the vendors on regu-
lar basis under supervision of trained cardiologist/s. This
model can help establish device therapy service at a sec-
ondary hospital without huge expenditure on infrastruc-
ture or facing the lack of recruitment of specialized
technical support that is difficult to find –especially for
smaller cities–. We present our experience at a 250 bed
secondary hospital, with a relatively small cardiac unit
(3 consultants, 5 hospitalists, 10 cardiac ECG/Echo techs)
and no cath lab of introduction of this service with the
help of nursing education department and vendors sup-
plying these devices as well as OR and radiology depart-
ments. Training of radiology technicians and OR nursing
staff on the basic procedural support with few in-service
demonstration helped prepare adequate staff helping
during implant procedures. Requirement of technical
support from the vendor –as a condition for purchase
of devices– during the implant and follow up clinics
helped overcome the lack of EP technicians. After
implant of more than 100 different devices (pacemakers,
AICD and BiV-AICD) the process became much
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